Kenwood, CA, United States of America

Gerald McMahon


Average Co-Inventor Count = 3.2

ph-index = 26

Forward Citations = 2,037(Granted Patents)


Inventors with similar research interests:


Location History:

  • Kenwood, CA (US) (1997 - 2007)
  • San Francisco, CA (US) (1998 - 2007)

Company Filing History:


Years Active: 1997-2007

Loading Chart...
Areas of Expertise:
Indolinone Combinatorial Libraries
Protein Kinase Inhibitors
Tyrosine Kinase Inhibitors
Serine/Threonine Protein Kinase Modulation
Quinazoline-Based Compounds
Azaindole Compounds
Tricyclic Quinoxaline Derivatives
Heteroarylcarboxamide Compounds
Phosphate Mimics
Bioavailability of Indolinones
Tyrphostin Like Compounds
Pharmaceutical Compositions
65 patents (USPTO):Explore Patents

Title: The Innovative Journey of Gerald McMahon

Introduction

Gerald McMahon, based in Kenwood, California, is a prominent inventor known for his significant contributions to the field of biotechnology. With an impressive portfolio of 65 patents, McMahon has made substantial advancements in therapeutic compounds aimed at addressing critical medical conditions.

Latest Patents

Among his latest inventions, McMahon focuses on compounds that inhibit the activity of receptor tyrosine kinases, specifically targeting conditions such as cell proliferative disorders and cancers linked to c-kit kinase activity. His work includes the development of indolinone combinatorial libraries, which are organic molecules designed to modulate and inhibit protein kinase signal transduction. These compounds have implications for treating various diseases, including cancer, atherosclerosis, arthritis, restenosis, and diabetes. His innovative indolinone compounds, particularly those modified with specific chemical substituents, have shown promise in effectively activating and inhibiting protein kinases.

Career Highlights

Throughout his career, Gerald McMahon has worked with notable companies in the biotechnology sector, including Sugen Incorporated and Asta Medica, Aktiengesellschaft. His tenure at these firms has not only advanced his research but has also established him as a notable figure in pharmaceutical innovation.

Collaborations

McMahon has collaborated with prominent colleagues in the field, including Peng Cho Tang and Li Hsiang Sun. Together, they have contributed to the development of breakthrough research that pushes the boundaries of current medical treatments.

Conclusion

Gerald McMahon's inventive spirit and dedication to solving complex health issues through innovation continue to make a significant impact. With a strong patent portfolio and collaborative efforts, he remains a key player in advancing therapeutic solutions that address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…